Este site utiliza cookies para lhe proporcionar uma melhor experiência de utilização. Ao navegar aceita a política de cookies.
OK, ACEITO

Program 

The event will take place at Central Auditorio — Polo III, University of Coimbra | PDF

27th September 2018


9:00 - 9:30h - OPENING SESSION

João Gabriel Silva | Rector - UC

Francisco Veiga | Director Faculty of Pharmacy University of Coimbra 

Amílcar Falcão | Drugs R&D PhD Program Director

9:30H – 13:00H: SOCIO ECONOMIC PERSPECTIVE

Chair: Luis Almeida | MD, PhD, Founder and Managing Director at Blueclinical Ltd and President of the College of Clinical Pharmacologists.

Ana Paula Martins | PharmD, PhD, Bastonária - Ordem dos Farmacêuticos

Hélder Mota-Filipe | PharmD, PhD – INFARMED & FFUL

Patrícia Calado | PhD, Delegate and National Contact Point for Health in Horizon 2020 - FCT/ANI

Coffee Break

Ana Castro | MD, PhD, President - Health Parliament Portugal

Rui Mesquita | MD, MBA, PhD, Customer Engagement Manager - MSD 

Pannel Discussion

Lunch

14:30H – 18:00H: CORPORATE PERSPECTIVE

Chair: Cecília Rodrigues | PharmD, PhD, Director i3DU PhD Program, FFUL

Chair: Jorge Correia-Pinto | MD, PhD, Director PhD-iHES – Uminho

Ana Paula Duarte | PharmD, PhD, Head of CICS – UBI

João Ramalho-Santos | PhD, President – CNC

Antero Abrunhosa | PhD, Director - ICNAS-Produção

Catarina Cardoso | PharmD - Laboratórios Basi

Coffee Break

Tino Rossi | PhD, Head of Chemistry – BIAL

Sérgio Simões | PharmD, PhD, Vice-President – Bluepharma

Rui Loreiro | PhD, Process Chemist Development, Director - Hovione



28th September 2018

9:00H – 13:00H: LEADERS PERSPECTIVE

Chair: Nuno Afonso | PhD, MBA, Investment Manager, Life Sciences - Portugal Ventures

João José Sousa | PharmD, PhD - Dendropharma & FFUC

Lino Ferreira | PhD, CSO and Co-founder – Matera & Group Leader – CNC

Teresa Cruz Rosete | PharmD, PhD, Co-founder - ToxFinder & Group Leader – CNC

Coffee Break

Vera Moura | PharmD, PhD, CEO - Treat-U

Joana Simões Correia | PhD, Founder, Executive Director & CSO - Exogenus Therapeutics

André Gomes | PhD, CEO & Founder - Crioestaminal

Closing RemarksJoão Calmeiro| MSc, PhD Student – FFUC


Program subjected to be changed